TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Applied DNA Sciences ( (APDN) ) has issued an update.
On July 2, 2025, Applied DNA Sciences, Inc. received a notice from Nasdaq confirming that the company has regained compliance with the Nasdaq Capital Market’s listing requirements, specifically maintaining a minimum bid price of $1.00 per share. As a result, a previously scheduled hearing with the Nasdaq Hearings Panel has been cancelled, and the company’s securities will continue to be listed and traded on Nasdaq, ensuring stability in its market presence.
Spark’s Take on APDN Stock
According to Spark, TipRanks’ AI Analyst, APDN is a Neutral.
Applied DNA Sciences faces substantial financial and operational challenges, as indicated by declining revenues and net losses. Despite some positive strategic moves, such as focusing on LineaRx, the stock suffers from poor technical indicators and valuation metrics. The company’s ongoing financial struggles and the uncertainties highlighted in the earnings call contribute to a low overall stock score.
To see Spark’s full report on APDN stock, click here.
More about Applied DNA Sciences
Average Trading Volume: 104,320
Technical Sentiment Signal: Strong Sell
Current Market Cap: $2.4M
For a thorough assessment of APDN stock, go to TipRanks’ Stock Analysis page.